Research & Development

Igniting the Baxalta Spark

Baxalta focuses its innovation towards the development of life-saving therapies for orphan conditions in Haematology, Immunology and Oncology, specifically in areas of unmet need. Our broad and diverse pipeline includes biologics with novel mechanisms and advanced technology platforms such as gene therapy.

In addition, our R&D model is built around the patient, focused on targeted orphan diseases. By embracing new technologies and approaches, including biomarkers and companion diagnostics to stratify patient populations, and leveraging the power of informatics to improve R&D productivity, we are poised to continue innovating and deliver new treatments for our patients.